Emerging regulatory model of Ubiquitin-Specific Proteases 14 in cancer: from canonical oncogenesis to TME modulation, therapeutic resistance, and non-canonical activities

RuoFeng Wang, Fang Yan, Fengrui Duan, Weikai Xia, Wenbo Wang, Zhenxiang Wang, Fulin Sun, Chunjuan Yu, Huhu Zhang, Lina Yang · 2026

Read Emerging regulatory model of Ubiquitin-Specific Proteases 14 in cancer: from canonical oncogenesis to TME modulation, therapeutic resistance, and non-canonical activities by RuoFeng Wang, Fang Yan, Fengrui Duan, Weikai Xia, Wenbo Wang, Zhenxiang Wang, Fulin Sun, Chunjuan Yu, Huhu Zhang, Lina Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13563959.txt.

Description

RuoFeng Wang leads a 2026 review of USP14, a protein that removes ubiquitin tags and sits on the cell's protein-recycling machinery, and of its widening role in cancer. Once seen mainly as a helper that stabilizes cancer-promoting proteins, it now links to the tumor surroundings and to treatment resistance. It also has jobs that do not involve its cutting action at all.

The review maps how chemical changes switch USP14 on, how it helps tumors resist targeted drugs, chemotherapy, radiation, and immune therapy, and where it can surprisingly slow tumors instead. Readers working on new cancer drugs get a systems view of one regulator and the openings it may offer for treatment.

Catalog record

CREATORRuoFeng Wang, Fang Yan, Fengrui Duan, Weikai Xia, Wenbo Wang, Zhenxiang Wang, Fulin Sun, Chunjuan Yu, Huhu Zhang, Lina Yang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE57351
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13563959

Browse the full library · About the Tower of Babel